Vicarious Surgical Inc.
RBOT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $352 | $0 | $0 | $542 |
| Gross Profit | -$352 | $0 | $0 | -$542 |
| % Margin | – | – | – | – |
| R&D Expenses | $7,641 | $9,050 | $9,415 | $7,921 |
| G&A Expenses | $0 | $4,120 | $5,291 | $0 |
| SG&A Expenses | $3,510 | $4,469 | $6,332 | $6,515 |
| Sales & Mktg Exp. | $0 | $349 | $1,041 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $11,151 | $13,519 | $15,747 | $14,436 |
| Operating Income | -$11,503 | -$13,519 | -$15,747 | -$14,978 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $445 | $304 | $353 | $1,052 |
| Pre-Tax Income | -$11,058 | -$13,215 | -$15,394 | -$13,926 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11,058 | -$13,215 | -$15,394 | -$13,926 |
| % Margin | – | – | – | – |
| EPS | -1.86 | -2.23 | -2.6 | -2.36 |
| % Growth | 16.6% | 14.2% | -10.2% | – |
| EPS Diluted | -1.86 | -2.23 | -2.6 | -2.36 |
| Weighted Avg Shares Out | 5,938 | 5,938 | 5,924 | 5,912 |
| Weighted Avg Shares Out Dil | 5,938 | 5,938 | 5,924 | 5,912 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $264 | $446 | $594 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $352 | $413 | $369 | $542 |
| EBITDA | -$10,706 | -$13,106 | -$15,378 | -$13,384 |
| % Margin | – | – | – | – |